Analysis | Metabolite Name | Measured Value | Units | Exercise | Group | Sex | Type |
---|---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 2579 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 2950 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 3276 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 3541 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 3667 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 3767 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 4871 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 5518 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 5917 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 5961 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 6517 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 6611 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 6774 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 6981 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 6994 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 7455 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 7559 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 7616 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 7799 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 7818 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 8257 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 8281 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 8749 | Peak area normalized | No | LowRisk | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 8871 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 9204 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 9286 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 9685 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 10090 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 10151 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 10388 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 10669 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 10710 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 10738 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 11244 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 11430 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 11589 | Peak area normalized | Yes | LowRisk | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 11629 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 11847 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 12024 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 12297 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 12393 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 12964 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 13178 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 13480 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 13575 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 13677 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 13715 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 14318 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 14397 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 14475 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 14476 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 14524 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 14570 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 14692 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 14912 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 14913 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 15022 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 15123 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 15192 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 15353 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 15667 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 15763 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 15865 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 15965 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 16147 | Peak area normalized | Yes | Normal Pressures | Male | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 16516 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 16527 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 16724 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 16746 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 16769 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 17454 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 17743 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 17780 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 17843 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 17865 | Peak area normalized | No | Normal Pressures | Male | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 17906 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 18353 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 18397 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 18677 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 18748 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 18874 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 19485 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 19495 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 19776 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 19929 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 19975 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 20246 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 20305 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 20350 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 20870 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 21036 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 21062 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 21170 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 21173 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 21237 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 21355 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 21387 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 21433 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 21450 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 21520 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 21524 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 21662 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 21970 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 22356 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 22682 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 22692 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 22774 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 23049 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 23055 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 23082 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 23086 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 23309 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 23367 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 23671 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 23828 | Peak area normalized | No | LowRisk | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 24304 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 24403 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 24698 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 24742 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 24889 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 25020 | Peak area normalized | Yes | LowRisk | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 25065 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 25203 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 25688 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 25700 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 25997 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 26040 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 26230 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 26747 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 26771 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 26809 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 27147 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 27249 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 27359 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 27446 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 27735 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 28227 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 28487 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 29108 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 29660 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 29820 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 29920 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 29976 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 29988 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 30047 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 30157 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 30309 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 30713 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 31065 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 31214 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 32578 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 32581 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 32742 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 33070 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 33121 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 33721 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 33856 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 33939 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 34588 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 35202 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 37271 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 38566 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 38858 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 38906 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 39367 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 39461 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 40308 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 40353 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 40354 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 40366 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 40827 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 41178 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 41723 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 42159 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 42329 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 42469 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 42484 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 43456 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 43588 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 43684 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 44590 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 44905 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 45775 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 45777 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 47334 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 48747 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 49316 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 50660 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 51947 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 52306 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 52918 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 53634 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 61881 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 64427 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 79279 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 80219 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 80417 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 85575 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 93093 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 99580 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Return to search page